Orlando Silva
Hematology & Oncology · Miami, FLNPI 1689681868
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $17,440 of the $22,223 with a category attached, or 78.5%. 36 manufacturers reported payments, led by Pfizer at 34.4% of the total. Reporting peaked in 2019 at $21,240 and has fallen 99.5% since, to $114 in 2021.
Across 194 payments — averaging $114.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$8K
- Bristol Myers Squibb$7K
- Eisai Inc.$4K
- Merck$481
- Novartis$405
- Astellas Pharma US Inc$329
- plus $2K from 30 others
What the payments were for
- Speaking & faculty fees$17,44078%
- Travel & lodging$2811%
- Food & beverage$4,18719%
- Education$3151%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 26 | $7,635 |
| Bristol Myers Squibb | 20 | $7,319 |
| Eisai Inc. | 8 | $4,227 |
| Merck | 26 | $481 |
| Novartis | 22 | $405 |
| Astellas Pharma US Inc | 5 | $329 |
| Incyte Corporation | 8 | $180 |
| Lilly USA, LLC | 8 | $165 |
| AstraZeneca | 9 | $164 |
| Genentech USA, Inc. | 9 | $154 |
| Johnson & Johnson(2 entities) | 7 | $137 |
| E.r. Squibb & Sons, L.L.C. | 10 | $130 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $125 |
| Teva Pharmaceuticals USA, Inc. | 6 | $91 |
| Puma Biotechnology, Inc. | 2 | $82 |
| Tersera Therapeutics LLC | 2 | $81 |
| Amgen | 3 | $59 |
| Dova Pharmaceuticals | 3 | $58 |
| Rigel Pharmaceuticals, Inc. | 2 | $37 |
| Ipsen Biopharmaceuticals, Inc | 1 | $30 |
| Foundation Medicine, Inc. | 1 | $27 |
| Boehringer Ingelheim | 1 | $25 |
| Verastem, Inc. | 1 | $25 |
| Regeneron Healthcare Solutions, Inc. | 1 | $24 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $23 |
| Sanofi | 1 | $23 |
| Bayer | 1 | $23 |
| Kyowa Kirin, Inc. | 1 | $22 |
| Tesaro, Inc. | 1 | $21 |
| Array Biopharma Inc | 1 | $21 |
| Exelixis Inc. | 1 | $20 |
| GSK | 1 | $20 |
| Taiho Oncology, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $19 |
| Gilead | 1 | $12 |
| Agios Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$22,223 in reported general payments places this provider in the 70th percentile of 694 hematology & oncology providers in Florida.
Other hematology & oncology in Miami
- Steven FeinMiami$1M
- Srikanth NagallaMiami$639K
- Neil NagovskiMiami$530K
- Carl LandgrenMiami$517K
- Raja MudadMiami$422K
- George NahasMiami$364K
- Fernando de ZarragaMiami$333K
- Mikkael SekeresMiami$278K
- Krishna KomanduriMiami$187K
- Estelamari RodriguezMiami$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.